Fri, December 17, 2021

Chris Shibutani Initiated (ABBV) at Hold and Held Target at $113 on, Dec 17th, 2021

Chris Shibutani of Goldman Sachs, Initiated "AbbVie Inc." (ABBV) at Hold and Held Target at $113 on, Dec 17th, 2021.

Chris has made no other calls on ABBV in the last 4 months.



There are 10 other peers that have a rating on ABBV. Out of the 10 peers that are also analyzing ABBV, 2 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Luisa Hector of "Berenberg" Maintained at Hold and Held Target at $105 on, Wednesday, November 24th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021


These are the ratings of the 8 analyists that currently disagree with Chris


  • Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $165 on, Thursday, December 9th, 2021
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $129 on, Monday, November 29th, 2021
  • Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $132 on, Monday, November 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $129 on, Monday, November 1st, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $130 on, Monday, August 23rd, 2021